Skip to main content
Clinical Trials/NCT02582957
NCT02582957
Completed
Not Applicable

Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome

University of Minnesota15 sites in 1 country524 target enrollmentApril 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Respiratory Distress Syndrome
Sponsor
University of Minnesota
Enrollment
524
Locations
15
Primary Endpoint
Ventilator-free Days (VFDs)
Status
Completed
Last Updated
last year

Overview

Brief Summary

A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.

Detailed Description

Patients in intensive care units (ICUs) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation will be randomized to either usual care or usual care with the addition of sigh breaths given once every 6 minutes. Patients will be randomized to one of the two study arms as soon as possible, but not longer than 24 hours after initiation of invasive mechanical ventilation. Patients will be followed for 28 days to assess ventilator-free days (VFDs), mortality, ICU-free days, and the occurrence of complications.

Registry
clinicaltrials.gov
Start Date
April 1, 2016
End Date
October 8, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients in an intensive care unit (ICU) as a result of injuries resulting from penetrating or non-penetrating trauma who are intubated and receiving invasive mechanical ventilation who also have one or more of the following:
  • Traumatic brain injury
  • \> 1 long bone fractures
  • Shock on arrival in the Emergency Department (systolic BP \< 90 mmHg)
  • Lung contusion
  • Receipt of \> 6 units of blood

Exclusion Criteria

  • Inability to obtain consent from the patient or his/her legally authorized representative (LAR)
  • Unwillingness of the treating physician to use sigh ventilation as all treating physicians must have equipoise with respect to the intervention
  • Age limitations per Institutional Review Board regulations
  • Undergoing invasive mechanical ventilation for \> 24 hours, excluding any time during which the patient was being ventilated in the operating room, CT or IR, as this could represent too long a delay in instituting the intervention for it to have a chance of being effective
  • Presence of malignancy or other irreversible disease or condition for which the six month mortality is estimated to exceed 50% (e.g., chronic liver disease with a Child-Pugh Score of 10-15, malignancy refractory to treatment) as this could affect the clinical course and cloud interpretation of the endpoints
  • Women who are pregnant (negative pregnancy tests required on women of child-bearing age) per Human Subjects regulations
  • Prisoners, per Human Subjects regulations
  • Neurological condition that could impair spontaneous ventilation (e.g., C5 or higher spinal cord injury as this could affect the clinical course and cloud interpretation of the ventilator-free day endpoint
  • Lack of availability of Dräger Evita Infinity V500 ventilator as this is the only ventilator capable of delivering sigh breaths as described in the protocol
  • Burns \> 40% of body surface area as this could affect the clinical course and cloud interpretation of the endpoints

Outcomes

Primary Outcomes

Ventilator-free Days (VFDs)

Time Frame: 28 days

Ventilator-free days (VFDs), defined as the number of days of unassisted breathing to day 28 without having to re-institute invasive ventilation. Patients who died before day 28 were assigned 0 VFDs as were those transferred to a long-term care facility while ventilated.

Secondary Outcomes

  • Number of Participants With Complications of Treatment(28 days)
  • Discharge Status(28 days)
  • All-cause Mortality(28 days)
  • ICU-free Days(28 days)
  • Number of Participants Requiring Oxygen Therapy at Discharge(28 days)

Study Sites (15)

Loading locations...

Similar Trials